413 results in Exploration of Targeted Anti-tumor Therapy
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
Bile-based liquid biopsy in cholangiocarcinoma: current evidence, clinical applications and future directions
Rita Andrade ... José Guilherme Tralhão
Published: November 18, 2026 Explor Target Antitumor Ther. 2026;7:1002413
153 6 0
Open Access Review
Unmet needs beyond precision in gastrointestinal cancers
Alessandro Ottaiano ... Guglielmo Nasti
Published: November 11, 2026 Explor Target Antitumor Ther. 2026;7:1002412
253 12 0
Open Access Original Article
Macrophage-like phenotypes of tumor-immune hybrid cells in primary breast cancer
Evgeniya S. Grigoryeva ... Liubov A. Tashireva
Published: November 09, 2026 Explor Target Antitumor Ther. 2026;7:1002411
250 8 0
Open Access Systematic Review
Targeting the immune microenvironment in blastic plasmacytoid dendritic cell neoplasm: a genomic perspective
Luigi Cimmino ... Pier Paolo Piccaluga
Published: October 27, 2026 Explor Target Antitumor Ther. 2026;7:1002410
492 29 0
Open Access Review
Proteoglycans as regulators of cancer biomarker landscapes: implications for precision oncology
Aikaterini Berdiaki ... Dragana Nikitovic
Published: October 27, 2026 Explor Target Antitumor Ther. 2026;7:1002409
437 20 0
Open Access Review
Study of the relationship between transposable elements and microRNAs in the development of glioblastoma for its targeted therapy
Rustam Mustafin
Published: October 20, 2026 Explor Target Antitumor Ther. 2026;7:1002408
510 24 0
Open Access Review
Perioperative immune checkpoint inhibition in head and neck squamous cell carcinoma: a 10-year review
Henry Freeman ... Mehrdad Pahlevani
Published: October 19, 2026 Explor Target Antitumor Ther. 2026;7:1002406
567 15 0
Open Access Review
Wound healing and recurrence in head and neck cancer: a narrative review
Micah K. Harris ... Matthew E. Spector
Published: October 15, 2026 Explor Target Antitumor Ther. 2026;7:1002405
499 11 0
Open Access Meta-Analysis
Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis
Ramaditya Srinivasmurthy ... Kyaw Zin Thein
Published: September 28, 2026 Explor Target Antitumor Ther. 2026;7:1002403
928 25 0
Open Access Original Article
Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution
Kei Nakagawa ... Michiaki Unno
Published: September 18, 2026 Explor Target Antitumor Ther. 2026;7:1002402
772 22 0
Open Access Review
Cardiotoxicity in breast cancer patients treated with chemoradiotherapy
Peter Emerson, Liza Thomas
Published: September 14, 2026 Explor Target Antitumor Ther. 2026;7:1002401
903 17 0
Open Access Perspective
Mitochondrial checkpoint for interferon responses in macrophages
Andreas O. Mieland, Oliver H. Krämer
Published: August 19, 2026 Explor Target Antitumor Ther. 2026;7:1002399
1045 28 0
Open Access Review
Precision oncology in the treatment of patients with bone sarcomas: an up-to-date narrative review
Sude Yarar, Panagiotis Tsagkozis
Published: August 09, 2026 Explor Target Antitumor Ther. 2026;7:1002396
1446 26 0
Open Access Original Article
Safety and efficacy of delivering systemic treatments concomitantly with whole-brain radiotherapy: a prospective, observational, single-institution study
Maria Protopapa ... Anna Zygogianni
Published: August 07, 2026 Explor Target Antitumor Ther. 2026;7:1002395
985 12 0
Open Access Review
Liquid biopsy in breast cancer: current biomarker platforms and clinical applications
Pritam Saha Podder ... Stefano Cinti
Published: August 05, 2026 Explor Target Antitumor Ther. 2026;7:1002394
1941 35 1